lobbying_activities: 924221

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
924221	a107e0fa-c219-4097-8676-5db72c0d5a08	Q1	MEHLMAN CONSULTING, INC.	284950	ABBOTT LABORATORIES	2010	first_quarter	PHA	S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act. H.R. 4872, The Health Care and Education Reconciliation Act of 2010. FDA reforms; Medicare coverage and reimbursement. Follow on Biologics: H.R.1548, Pathway for Biosimilars Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2010-04-19T16:43:41.100000-04:00